UTSW, UT advanced computing center share big-data tools in fight against cancer, infectious diseases: June 2017 News Releases - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2017/advanced-computing-center.html

UT Southwestern scientists who created a powerful analytic weapon in the fight against cancer and infectious diseases are making that tool available for free via a web-based portal.

CPRIT awards faculty $19.6 million for research in cervical, breast, lung, colon, kidney, and pediatric cancers, and cancer biology: November 2015 News Releases - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2015/cprit-awards-faculty-nr.html

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UTSW researchers more than $19.6 million in grants.

DNA sensor plays critical role in cancer immunotherapy via robust response to unexpected form of DNA: August 2017 News Releases - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2017/cancer-immunotherapy.html

UT Southwestern Medical Center researchers report for the first time that tumors stressed by cancer immunotherapy release their mitochondrial DNA into nearby immune cells, triggering a host alert system.

Immunotherapy superior to chemotherapy for lung cancer in international trial involving UT Southwestern cancer researchers: September 2015 News Releases - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2015/immunotherapy-gerber.html

An international team of cancer researchers that included UT Southwestern Medical Center physicians announced “game-changing results” using the immunotherapy drug nivolumab to treat certain lung cancers that failed to respond to first-line therapies.

Study finds no reason for cancer survivors to be excluded in advanced stage lung cancer trials: February 2015 News Releases - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2015/lung-cancer-trials.html

The common practice of excluding patients with a prior cancer diagnosis from lung cancer clinical trials may not be justified, according to a study by researchers from UT Southwestern Medical Center.

UT Southwestern targets rising rates of kidney cancer with four-pronged attack funded by National Cancer Institute: August 2016 News Release - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2016/spore-grant.html

The Kidney Cancer Program at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center received $11 million in funding from the National Cancer Institute.

Cancer care: Consider cancer risk when grilling: May 2016 Health and Wellness Tips - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2016/consider-cancer-risk.html

Health Tip: Cooking meat with high-temperature methods can increase exposure to chemicals that can cause changes in DNA that may increase the risk of cancer.

Simmons Cancer Center joins elite group of cancer centers with NCI’s highest level of designation: 2016 Southwestern Medicine - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2016/simmons-elite-designation.html

In 2005, Dr. James Willson, Director of the Harold C. Simmons Comprehensive Cancer Center, announced UT Southwestern’s intentions to become a National Cancer Institute-designated Comprehensive Cancer Center, the top tier for U.S. cancer centers.

New class of anti-cancer drug effective against kidney cancer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2017/kidney-cancer-drug.html

A novel drug belonging to a new class of medicines called HIF-2 inhibitors show promise in treating metastatic kidney cancer.

Cancer researchers first in Texas to use new prostate rectal spacer to minimize side effects of SABR radiation treatments: September 2015 News Releases - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2015/prostate-spacer.html

UT Southwestern Medical Center cancer researchers are investigating whether an injectable, biodegradable gel can reduce potential side effects from extreme high-dose radiation treatments for prostate cancer.